Epidemiological studies have round an association between elevated levels o
f particulate matter (PM) air pollution and increased medication use and ho
spital visits by asthmatics. While it is known that asthmatics are generall
y more sensitive to airborne contaminants such as sulfur dioxide and tobacc
o smoke, it is difficult to test which components of air pollution may also
contribute to the induction of pulmonary allergy (sensitization) because o
f the risk in creating disease. Recent studies in mice and rats, however, h
ave demonstrated that pulmonary exposure to combustion particles such as di
esel and residual oil ny ash (ROFA) can exacerbate immunological sensitizat
ion tin the form of immunoglobulin E antibody and lymphocyte reactivity) to
experimental and natural allergens. Subsequent allergen challenge in these
animals results in a greater allergen-induced bronchoconstriction, elevate
d numbers of eosinophils in the lung, and enhanced airway responsiveness to
cholinergic agents compared to what occurs in similarly immunized animals
pretreated with vehicle or "inert" particles. Although the mechanisms for t
hese effects are not known, it has been demonstrated that the adjuvant effe
cts of diesel and ROFA can be reproduced with hydrocarbons and soluble tran
sition metals from diesel and ROFA, respectively. in addition, analysis of
mediator expression and release over the sensitization phase has revealed t
hat PM exposure can enhance production of Th2 cytokines such as interleukin
-5 (IL-5) and the proinflammatory cytokine tumor necrosis factor-alpha (TNF
-alpha). These experimental systems demonstrate the potential of particulat
e air pollutants to enhance allergic sensitization and can be further used
to elucidate the mechanism for these effects.